This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 742974 Submitted by lobbyist on: February 27, 2018 05:10:32 PM Accepted by Registrar on: February 28, 2018 11:40:23 AM
Designated Filer Information
Badger, Derek
550 Guernsey Ave.
Penticton, BC, V2A 1C3
250-486-0194
Canada
Organization Information
Janssen Inc.
Innovative/brand pharmaceuticals.
19 Green Belt Drive
Toronto, ON, M3C 1L9
800-387-8781
Canada
Relevant Affiliates
The client has no relevant affiliates.
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Active Registration Period
February 27, 2018
August 27, 2018
Organization's In-House Lobbyists
Name:
Badger, Derek
February 27, 2018
Inactivation Date:
September 18, 2018
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Discuss issues related to existing and future policies that do/may affect Janssen's pharmaceutical products as well as clinical research activities/investments.
Target Contacts
Target Type
Name
Title or Constituency
Date Added
MLA
Bernier,
Mike
Peace River South
February 27, 2018
MLA
Dix,
Adrian
Vancouver-Kingsway
February 27, 2018
MLA
Ralston,
Bruce
Surrey-Whalley
February 27, 2018
Name:
Debolt, Michael
February 27, 2018
Inactivation Date:
September 18, 2018
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Discuss issues related to existing and future policies that do/may affect Janssen's pharmaceutical products as well as clinical research activities/investments.
